Andre L Moreira Selected Research

Andre L Moreira Research Topics

Disease

35	Neoplasms (Cancer) 04/2024 - 11/2007
16	Lung Neoplasms (Lung Cancer) 02/2024 - 11/2012
15	Adenocarcinoma 02/2024 - 06/2010
15	Adenocarcinoma of Lung 01/2024 - 11/2010
7	Inflammation (Inflammations) 01/2024 - 04/2002
7	Infections 01/2022 - 04/2002
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 03/2011
6	Thymoma (Thymic Carcinoma) 01/2024 - 03/2014
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2024 - 06/2010
5	Carcinoma (Carcinomatosis) 01/2023 - 02/2008
4	COVID-19 01/2022 - 12/2020
4	Granuloma 12/2003 - 04/2002
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 04/2024 - 08/2014
2	Carcinogenesis 09/2023 - 02/2015
2	Aortic Valve Stenosis (Aortic Stenosis) 06/2023 - 01/2023
2	Fibrosis (Cirrhosis) 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 12/2014 - 08/2012
2	Squamous Cell Carcinoma of Head and Neck 08/2012 - 04/2012
2	Leukocytosis (Pleocytosis) 04/2006 - 07/2005
2	Visceral Leishmaniasis (Kala Azar) 08/2003 - 11/2002
1	Mediastinal Fibrosis 01/2023
1	Amyloid Plaque 01/2023
1	Pathologic Constriction (Stenosis) 01/2023
1	Hodgkin Disease (Hodgkin's Disease) 01/2023
1	Aortic Valve Disease 01/2023
1	Lymphoma (Lymphomas) 01/2023
1	Vaccinia 01/2023
1	Pathologic Complete Response 05/2022
1	Thrombosis (Thrombus) 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2021
1	Lung Diseases (Lung Disease) 07/2021
1	Malignant Mesothelioma 06/2021
1	Infarction (Infarctions) 01/2021
1	Neoplasms, Cystic, Mucinous, and Serous 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Adenoma (Adenomas) 01/2021
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 09/2020
1	Transthyretin-Related Hereditary Amyloidosis 09/2020
1	Dyspnea (Shortness of Breath) 09/2020
1	Diverticulitis 09/2020
1	Hyperplasia 10/2019

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 02/2024 - 02/2012
5	B7-H1 AntigenIBA 01/2023 - 01/2019
5	AntibodiesIBA 01/2023 - 01/2012
5	Proteins (Proteins, Gene)FDA Link 10/2020 - 07/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2010 - 04/2002
3	Amyloid (Amyloid Fibrils)IBA 06/2023 - 09/2020
3	ParaffinIBA 10/2020 - 06/2010
3	Messenger RNA (mRNA)IBA 01/2017 - 11/2002
3	ErbB Receptors (EGF Receptor)IBA 12/2014 - 09/2013
3	Tyrosine Kinase InhibitorsIBA 12/2014 - 01/2012
3	Interferon-gamma (Interferon, gamma)IBA 12/2003 - 04/2002
3	CytokinesIBA 08/2003 - 04/2002
2	xylometazoline (stas)IBA 01/2024 - 01/2022
2	Immune Checkpoint InhibitorsIBA 11/2023 - 04/2015
2	GlutaminaseIBA 11/2023 - 11/2017
2	AntigensIBA 07/2023 - 04/2002
2	SmokeIBA 01/2023 - 10/2019
2	LigandsIBA 01/2022 - 03/2010
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2021 - 12/2020
2	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2021 - 12/2020
2	Formaldehyde (Formol)FDA Link 10/2020 - 01/2019
2	Thyroid Nuclear Factor 1IBA 01/2019 - 04/2018
2	InterleukinsIBA 03/2010 - 08/2003
2	VaccinesIBA 04/2006 - 04/2002
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2003 - 11/2002
2	Interleukin-12 (IL 12)IBA 08/2003 - 11/2002
2	Interleukin-10 ReceptorsIBA 08/2003 - 11/2002
1	sotorasibIBA 02/2024
1	adagrasibIBA 02/2024
1	AutoantibodiesIBA 01/2024
1	Capsules (Microcapsules)IBA 01/2024
1	AntioxidantsIBA 11/2023
1	Hematoxylin (Haematoxylon)IBA 09/2023
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2023
1	Neutralizing AntibodiesIBA 07/2023
1	ApolipoproteinsIBA 01/2023
1	Immunoglobulin G (IgG)IBA 01/2023
1	Antisense OligonucleotidesIBA 01/2023
1	AfatinibIBA 01/2023
1	SHP099IBA 01/2023
1	CollagenIBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	AsbestosIBA 06/2021
1	Colloids (Colloid)IBA 01/2021
1	Coloring Agents (Dyes)IBA 12/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2020
1	AA amyloidosisIBA 09/2020
1	diphosphoric acid (pyrophosphoric acid)IBA 09/2020
1	CarcinogensIBA 10/2019

Therapy/Procedure

20	Therapeutics 02/2024 - 01/2011
7	Immunotherapy 11/2023 - 11/2002
3	Radiotherapy 01/2018 - 03/2014
3	Drug Therapy (Chemotherapy) 06/2015 - 11/2002
2	Neoadjuvant Therapy 04/2024 - 05/2022
1	Thrombectomy 01/2022
1	Lung Transplantation 07/2021
1	Contraindications 07/2021
1	Extracorporeal Membrane Oxygenation 01/2021
1	Colectomy 09/2020